Showing results (141-150 of 315) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trialEdward M Messing, Judith Manola, George Wilding, et al.The Journal of Urology|July 28, 2011
Validation of the modified American Urological Association symptom scoreE David Crawford, Colin I O'Donnell, Al B Barqawi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2010
Comorbidity and mortality results from a randomized prostate cancer screening trialE David Crawford, Robert Grubb, Amanda Black, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trialThomas W Flaig, Catherine M Tangen, Maha H A Hussain, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinomaStephen A Boorjian, Matthew I Milowsky, Jodi Kaplan, et al.BJU International|January 17, 2007
Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trialPaul F Pinsky, E David Crawford, Barnett S Kramer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group studyRobert P Whitehead, Danika Lew, Robert C Flanigan, et al.Cancer Research|March 18, 2004
Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptorLin Qi, Terry M Nett, Matthew C Allen, et al.Human Pathology|July 17, 2004
Biomorphometric analysis of human prostatic carcinoma by using three-dimensional computer modelsPriya N Werahera, Gary J Miller, Kathleen Torkko, et al.The Prostate|July 21, 2004
The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trialAli Ziada, Albaha Barqawi, L Michael Glode, et al.Pageof 32